The solid-state battery developer Adden Energy, founded by scientists from Harvard University, has commissioned a pilot ...
Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...
Discover how Revvity's strategic acquisitions and financial improvements position it for long-term growth in cell and gene ...
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive ...
Repligen expects full-year earnings in the range of $1.67 to $1.76 per share, with revenue in the range of $685 million to $710 million. This story was generated by Automated Insights ( ...
Top-line results from SUMMIT trial in NonAdvSM patients expected July 2025• APEX trial enrollment in AdvSM patients complete; top-line results ...
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Ardelyx Inc. (ARDX) on Thursday reported fourth-quarter net income of $4.6 million, after reporting a loss in the same period a year earlier. The Waltham, ...
Arthur J. Gallagher & Co. said it has acquired Agilis Partners LLC, an investment and retirement plan consulting firm based ...
Hosted on MSN1d
UBS Upgrades RTX (RTX)
Fintel reports that on February 24, 2025, UBS upgraded their outlook for RTX (NYSE:RTX) from Neutral to Buy. Analyst Price ...
Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...